Post-locoregional treatment imaging of hepatocellular carcinoma

Approximately 80% of cirrhotic patients with locoregional hepatoma cannot be managed surgically and are classified as unresectable. Treatment of hepatocellular carcinoma (HCC), however, includes a multitude of locoregional therapies that can variously be used with curative or non-curative intent. These therapies are known to increase overall survival and disease-free survival in those patients for whom surgical resection is not appropriate.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.